Storystream | TEKGROUP Online Newsroom Software


Jan 14, 2022

1:01:00 PM ET — via AbbVie
U.S. FDA Approves RINVOQ® (upadacitinib) to Treat Adults and Children 12 Years and Older with Refractory, Moderate to Severe Atopic Dermatitis

NORTH CHICAGO, Ill., Jan. 14, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of moderate to severe atopic dermatitis in adults and children 12 years of age and older whose disease did not respond to previous treatment and is not well controlled with other pills or injections, including biologic medicines, or when use of other pills or injections is not recommended.1 RINVOQ 15 mg once daily can be initiated in adults and children 12 years of age and older weighing at least 40 kg.1 In these children and adults less than 65 years of age who do not achieve an adequate response, the dose may be increased to 30 mg once daily.1

10:16:00 AM ET — via Delaware North
Buffalo Bills and Delaware North introduce new specialty food and beverage items for Wild Card matchup

9:00:00 AM ET — via Motorola
Motorola Solutions Introduces Curve Wi-Fi Enhanced Business Radio with Voice Assistance

8:00:00 AM ET — via Walgreens
Walgreens Update on Insurance Reimbursement for Over-the-Counter COVID-19 Tests

Jan 13, 2022

2:39:00 PM ET — via Vail Resorts
Combating Climate Change: Vail Resorts Announces $3.6 Million Across 19 Resorts in Largest Single-Year Energy Efficiency Investment

8:59:00 AM ET — via Accenture
Novetta, Part of Accenture Federal Services, Strikes Deal with the U.S. Air Force to Resell Platform One Products
ARLINGTON, Va.; Jan. 13, 2022 – Accenture Federal Services (AFS) is pleased to announce that Novetta, an advanced analytics company acquired in August 2021 by AFS, has entered into a first-of-its-kind agreement to commercialize Platform One, the U.S. Air Force’s (USAF) software development platform. Specifically, the two-year deal allows Novetta to resell and support the platform’s Iron Bank and Big Bang products, thus expanding the Platform One footprint across federal government and industry partners alike.

8:29:00 AM ET — via Accenture
Accenture Expands Apprenticeship Hiring to 20% of US Entry-Level Roles
NEW YORK; Jan. 13, 2022 – Accenture (NYSE: ACN) today announced that it is expanding its apprenticeship program in the United States to give more people access to digital economy jobs and further advance its equitable approach to hiring, which focuses on skills, experiences and potential.  

7:17:00 AM ET — via AbbVie Stories
Then and now: A renaissance in blood cancer treatment
See how scientists have nearly doubled some survival rates in a generation, with even more scientific discoveries on the horizon.

Jan 12, 2022

10:29:00 AM ET — via Accenture
Accenture Named a Leader Among Global Cybersecurity Providers in Independent Report
NEW YORK; Jan. 12, 2022 – Accenture (NYSE: ACN) has been named a Leader in the latest Forrester Research report on global cybersecurity consulting providers, which notes that Accenture “earns credibility with tech expertise but proves it with vertical knowledge.”

2:00:00 AM ET — via Motorola
Motorola Solutions Showcases its Integrated Technology Ecosystem at Intersec 2022 in Dubai

Jan 11, 2022

3:43:00 PM ET — via Delaware North
Gaming locations step up for tornado disaster relief efforts
After devastating tornadoes struck the Mid-South region of the United States in early December, two Delaware North gaming locations jumped into action to donate money and assist in disaster relief efforts in their local communities.

9:00:00 AM ET — via Motorola
U.S. Navy Extends Critical Communications Contract with Motorola Solutions

8:01:00 AM ET — via AbbVie
AbbVie Confirms Guidance of Greater Than $15 Billion in Combined Risk-Adjusted Sales for Rinvoq and Skyrizi in 2025

NORTH CHICAGO, Ill., Jan. 11, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) is confirming prior revenue guidance of greater than $15 billion in combined Rinvoq (upadacitinib) and Skyrizi (risankizumab) risk-adjusted sales in 2025. AbbVie now expects 2025 risk-adjusted sales of greater than $7.5 billion for Rinvoq and greater than $7.5 billion for Skyrizi. The new Rinvoq sales guidance is the result of lower expected Rinvoq sales in the U.S. following the recent label updates in approved indications, partially offset by higher anticipated sales in international markets, as well as higher anticipated global sales in Crohn's disease and ulcerative colitis following positive Phase 3 study readouts. The updated Skyrizi sales guidance is based on continued strong performance in psoriasis.

7:59:00 AM ET — via Accenture
New Book "The Automation Advantage" Shows Organizations How to Achieve Full Value from Intelligent Automation
NEW YORK; Jan.11, 2022 – As organizations continue to execute compressed transformation strategies and increase their investments in automation technology, a new book authored by three top automation experts at Accenture (NYSE: ACN) provides an in-depth look at how intelligent automation has become one of the most powerful means of driving performance and value across organizations.

1:59:00 AM ET — via Accenture
Accenture Helps Tokio Marine Kiln Transform Its Finance and HR Functions in the Cloud with Workday
LONDON; Jan. 11, 2022 – Accenture (NYSE: ACN) has collaborated with Tokio Marine Kiln (TMK), a leading international insurer, to transform its finance and human resources (HR) functions in the U.K. and Singapore by digitizing and consolidating multiple systems onto Workday (NASDAQ: WDAY).

Jan 10, 2022

4:29:00 PM ET — via Ameriprise Financial
Stocks Look to Regroup Following A Shaky Start to the New Year
The ongoing bond market adjustment to the threat of tighter monetary policy accelerated last week, as yields jumped at the start of trading in the new year. The expectation of higher rates was reinforced during the week, first by the minutes of the Fed’s December meeting, followed by the solid December jobs report. The yield on the U.S. ten-year note surged 25 basis points higher on the week to 1.76 percent, its highest in two years, dating back to just prior to the onset of the pandemic. The bond market adjustment began in September when the Fed first hinted at tapering. Back then the ten-year note was yielding 1.30 percent. The more Fed sensitive two-year note has climbed from 0.20 to 0.86 percent since September, after rising 14 basis points last week. For the week, the Bloomberg Barclays U.S. Aggregate Bond index fell 1.5 percent. 

9:28:00 AM ET — via National Peanut Board
Peanuts and Sustainability FAQs
It is easy to talk about peanuts and sustainability. Peanuts are a naturally sustainable crop and one of nature’s original “zero-waste” plants. From roots to shells, every part is utilized throughout the planting, growing, harvesting and production process. Peanuts are water efficient, enrich the soil with fertilizer and farmers are producing more peanuts on the same land with fewer inputs.

7:59:00 AM ET — via Accenture
HFS Ranks Accenture the No.1 Provider for Energy Services
NEW YORK; Jan. 10, 2021 – Accenture (NYSE: ACN) has been ranked as the number one provider for energy services in the latest Top 10 Report 2021 from industry analyst firm HFS Research.

Jan 07, 2022

3:53:00 PM ET — via National Peanut Board
Meet the Newly Appointed Members and Alternates of the National Peanut Board
As announced in December, four members and four alternates from Georgia, South Carolina, Texas and Louisiana (At-Large) have been appointed to serve on the National Peanut Board. Here’s a little more about these farmer leaders who are volunteering their service for the industry.

previous next

You must be logged in to view this item.


This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.